341
Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:September 23, 2022Completed
Refractory Multiple Myeloma: 1454 Clinical Trials, Page 35 of 146
Hide Studies Not Open or Pending
342
Bendamustine Plus Bortezomib Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:November 25, 2013Completed
343
SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition(s):Recurrent Plasma Cell Myeloma; Refractory Plasma Cell MyelomaLast Updated:September 10, 2019Completed
344
Phase II Randomised Trial of Cyclophosphamide and Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma.
Condition(s):Multiple MyelomaLast Updated:January 23, 2020Unknown status
345
Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Participants With Relapsed or Refractory Multiple Myeloma Who Failed at Least 2 Prior Lines of Systemic Therapy
Condition(s):Multiple MyelomaLast Updated:November 16, 2020Completed
346
Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:May 11, 2012Withdrawn
347
Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and Lymphoma
Condition(s):Multiple Myeloma; LymphomaLast Updated:November 12, 2021Recruiting
348
Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:December 16, 2013Terminated
349
Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:November 21, 2019Completed
350
CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma.
Condition(s):Multiple MyelomaLast Updated:January 25, 2023Recruiting